In Vitro Diagnosis of Delayed-type Drug Hypersensitivity
- 1 August 2014
- journal article
- research article
- Published by Elsevier BV in Immunology and Allergy Clinics of North America
- Vol. 34 (3), 691-705
- https://doi.org/10.1016/j.iac.2014.04.009
Abstract
No abstract availableKeywords
This publication has 84 references indexed in Scilit:
- In vitro drug causality assessment in Stevens–Johnson syndrome – alternatives for lymphocyte transformation testClinical and Experimental Allergy, 2013
- Recovered Patients with Stevens–Johson Syndrome and Toxic Epidermal Necrolysis Maintain Long-Lived IFN-γ and sFasL Memory ResponsePLOS ONE, 2012
- Human leukocyte antigens (HLA) associated drug hypersensitivity: consequences of drug binding to HLAAllergy, 2012
- Drug hypersensitivity caused by alteration of the MHC-presented self-peptide repertoireProceedings of the National Academy of Sciences, 2012
- Characterization of the Antigen Specificity of T-Cell Clones from Piperacillin-Hypersensitive Patients with Cystic FibrosisJournal of Pharmacology and Experimental Therapeutics, 2012
- Mass Spectrometric Characterization of Circulating and Functional Antigens Derived from Piperacillin in Patients with Cystic FibrosisThe Journal of Immunology, 2011
- Enhanced antigenicity leads to altered immunogenicity in sulfamethoxazole-hypersensitive patients with cystic fibrosisJournal of Allergy and Clinical Immunology, 2011
- Direct Evidence for the Formation of Diastereoisomeric Benzylpenicilloyl Haptens from Benzylpenicillin and Benzylpenicillenic Acid in PatientsJournal of Pharmacology and Experimental Therapeutics, 2011
- Drug Antigenicity, Immunogenicity, and Costimulatory Signaling: Evidence for Formation of a Functional Antigen through Immune Cell MetabolismThe Journal of Immunology, 2010
- HLA-B*5701 Screening for Hypersensitivity to AbacavirNew England Journal of Medicine, 2008